Pregled pridržavanja terapije: metode merenja i intervencije
Sažetak
Pridržavanje propisanoj terapiji (adherenca) je od ključne važnosti za postizanje njenih ciljeva. Međutim, mnogi pacijenti se ne pridržavaju propisanog režima uzimanja lekova. Oko 50% pacijenata ne prati propisani režim uzimanja terapije, što čini adherencu rasprostranjenim problemom. Precizno praćenje adherence je od suštinskog značaja za planiranje delotvorne nege i intervencije. Ovaj rad daje pregled različitih metoda za procenu adherence, ističući prednosti i nedostatke svakog pristupa. Brojni faktori mogu uticati na adherencu. Ovaj pregled je usmeren na praktične načine merenja adherence i strategije za njeno unapređenje, naglašavajući njen značaj u postizanju boljih zdravstvenih rezultata. Zdravstveni radnici moraju dati prioritet adherenci jer ona direktno utiče na ishode lečenja i ukupne rezultate u javnom zdravlju.
Reference
Vervloet M, Linn AJ, van Weert JC, de Bakker DH, Bouvy ML, van Dijk L. The effectiveness of interventions using electronic reminders to improve adherence to chronic medication: a systematic review of the literature. J Am Med Inform Assoc. 2012;19(5):696–704. doi: 10.1136/amiajnl-2011-000748.
Wawruch M, Petrova M, Tesar T, Murin J, Schnorrerova P, Paduchova M, et al. Factors associated with non-adherence to angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in older patients with peripheral arterial disease. Front Pharmacol. 2023;14. doi: 10.3389/fphar.2023.1199669.
Baryakova TH, Pogostin BH, Langer R, McHugh KJ. Overcoming barriers to patient adherence: the case for developing innovative drug delivery systems. Nat Rev Drug Discov. 2023;22(5):387–409. doi: 10.1038/s41573-023-00670-0.
Kleinsinger F. The unmet challenge of medication nonadherence. Perm J. 2018;22:18–33. doi: 10.7812/TPP/18-033.
Iuga AO, McGuire MJ. Adherence and health care costs. Risk Manag Healthc Policy. 2014;7:35–44. doi: 10.2147/RMHP.S19801.
Aljofan M, Oshibayeva A, Moldaliyev I, Saruarov Y, Maulenkul T, Gaipov A. The rate of medication nonadherence and influencing factors: A systematic review. Electron J Gen Med. 2023;20(3):em471.
Demonceau J, Ruppar T, Kristanto P, Hughes DA, Fargher E, Kardas P, et al. Identification and assessment of adherence-enhancing interventions in studies assessing medication adherence through electronically compiled drug dosing histories: A systematic literature review and meta-analysis. Drugs. 2013;73(6):545–62. doi: 10.1007/s40265-013-0041-3.
Gossec L, Tubach F, Dougados M, Ravaud P. Reporting of adherence to medication in recent randomized controlled trials of 6 chronic diseases: a systematic literature review. Am J Med Sci. 2007;334(4):248–54. doi: 10.1097/MAJ.0b013e318068dde8.
Lehmann A, Aslani P, Ahmed R, Celio J, Gauchet A, Bedouch P, et al. Assessing medication adherence: Options to consider. Int J Clin Pharm. 2014;36(1):55–69. doi: 10.1007/s11096-013-9865-x.
Kardas P. From non-adherence to adherence: Can innovative solutions resolve a longstanding problem? Eur J Intern Med. 2024;119:6–12. doi: 10.1016/j.ejim.2023.10.012.
Mechler K, Hage A. Drugs don't work in patients who don't take them. Z Kinder Jugendpsychiatr Psychother. 2019;47(6):528–34. doi: 10.1024/1422-4917/a000645.
Adherence to long-term therapies: evidence for action [Internet]. World Health Organization; 2003 [cited 2025 May 29]. Available from: https://iris.who.int/bitstream/handle/10665/42682/9241545992.pdf.
Tibble H, Flook M, Sheikh A, Tsanas A, Horne R, Vrijens B, et al. Measuring and reporting treatment adherence: What can we learn by comparing two respiratory conditions? Br J Clin Pharmacol. 2021;87:825–36. doi: 10.1111/bcp.14458.
Vrijens B, Dima AL, Van Ganse E, van Boven JFM, Eakin MN, Foster JM, et al. What We Mean When We Talk About Adherence in Respiratory Medicine. J Allergy Clin Immunol Pract. 2016;4(5):802–12. doi: 10.1016/j.jaip.2016.05.019.
Brown MT, Bussell JK. Medication adherence: WHO cares? Mayo Clin Proc. 2011;86(4):304–14. doi: 10.4065/mcp.2010.0575.
George M, Bender B. New insights to improve treatment adherence in asthma and COPD. Patient Prefer Adherence. 2019;13:1325–34. doi: 10.2147/PPA.S209532.
Jimmy B, Jose J. Patient medication adherence: measures in daily practice. Oman Med J. 2011;26(3):155‒9. doi: 10.5001/omj.2011.38.
Bosworth HB, Granger BB, Mendys P, Brindis R, Burkholder R, Czajkowski SM, et al. Medication adherence: A call for action. Am Heart J. 2011;162(3):412‒424. doi: 10.1016/j.ahj.2011.06.007.
van Boven JF, Tsiligianni I, Potočnjak I, Mihajlović J, Dima AL, Nabergoj Makovec U, et al. European Network to Advance Best Practices and Technology on Medication Adherence: Mission Statement. Front Pharmacol. 2021;12:748702. doi: 10.3389/fphar.2021.748702.
Arbuckle C, Tomaszewski D, Brown L, Schommer J, Morisky D, Parlett-Pelleriti C, Linstead E. Exploring the relationship of digital information sources and medication adherence. Comput Biol Med. 2019;109:303‒310. doi: 10.1016/j.compbiomed.2019.04.023.
Partridge AH, Avorn J, Wang PS, Winer EP. Adherence to Therapy with Oral Antineoplastic Agents. J Natl Cancer Inst. 2002;94(9):652–61.
Kardas P, Lewek P, Matyjaszczyk M. Determinants of patient adherence: A review of systematic reviews. Front Pharmacol. 2013;4. doi: 10.3389/fphar.2013.00091.
Mondesir FL, Levitan EB, Malla G, Mukerji R, Carson AP, Safford MM, Turan JM. Patient perspectives on factors influencing medication adherence among people with coronary heart disease (CHD) and CHD risk factors. Patient Prefer Adherence. 2019;13:2017–27. doi: 10.2147/PPA.S222176.
Aljofan M, Oshibayeva A, Moldaliyev I, Saruarov Y, Maulenkul T, Gaipov A. The rate of medication nonadherence and influencing factors: A systematic Review. Electron J Gen Med. 2023;20(3):em471.
Chan AHY, Cooper V, Lycett H, Horne R. Practical barriers to medication adherence: What do current self- or observer-reported instruments assess? Front Pharmacol. 2020;11:572. doi: 10.3389/fphar.2020.00572.
Wroe AL. Intentional and unintentional nonadherence: a study of decision making. J Behav Med. 2002;25(4):355–72. doi: 10.1023/a:1015866415552.
Rusu RN, Ababei DC, Stanciu GD, Neamțu M, Macadan I, Anghel Lazăr CI, Bild V. Adherence to treatment – Reviewing methods of assessment and improvement. Farmacia. 2023;71(2):236–46.
Lehane E, McCarthy G. Intentional and unintentional medication non-adherence: a comprehensive framework for clinical research and practice? a discussion paper. Int J Nurs Stud. 2007;44(8):1468–77. doi: 10.1016/j.ijnurstu.2006.07.010.
Bae SG, Kam S, Park KS, Kim KY, Hong NS, Kim KS, et al. Factors related to intentional and unintentional medication nonadherence in elderly patients with hypertension in rural community. Patient Prefer Adherence. 2016;10:1979–89. doi: 10.2147/PPA.S114529.
Cutler RL, Fernandez-Llimos F, Frommer M, Benrimoj C, Garcia-Cardenas V. Economic impact of medication non-adherence by disease groups: a systematic review. BMJ Open. 2018;8:e016982. doi: 10.1136/bmjopen-2017-016982.
Arnet I, Haefeli WE. Compliance: Fakten Perspektiven. Manag Care. 1998;3:27–31.
Adams AJ, Stolpe SF. Defining and Measuring Primary Medication Nonadherence: Development of a Quality Measure. J Manag Care Spec Pharm. 2016;22(5):516–23. doi: 10.18553/jmcp.2016.22.5.516.
Kvarnström K, Westerholm A, Airaksinen M, Liira H. Factors Contributing to Medication Adherence in Patients with a Chronic Condition: A Scoping Review of Qualitative Research. Pharmaceutics. 2021;13(7). doi: 10.3390/pharmaceutics13071100.
Lam WY, Fresco P. Medication adherence measures: An overview. Biomed Res Int. 2015. doi:10.1155/2015/217047.
Anghel LA, Farcas AM, Oprean RN. An overview of the common methods used to measure treatment adherence. Med Pharm Rep. 2019;92(2):117–22. doi: 10.15386/mpr-1201.
Osterberg L, Blaschke T. Adherence to medication. N Engl J Med. 2005;353:487–97. doi: 10.1056/NEJMra050100.
Avataneo V, De Nicolò A, Rabbia F, Perlo E, Burrello J, Berra E, et al. Therapeutic drug monitoring-guided definition of adherence profiles in resistant hypertension and identification of predictors of poor adherence. Br J Clin Pharmacol. 2018;84(11):2535–43. doi: 10.1111/bcp.13706.
Farmer KC. Methods for measuring and monitoring medication regimen adherence in clinical trials and clinical practice. Clin Ther. 1999;21(6):1074–90. doi: 10.1016/s0149-2918(99)80026-5.
Kang JS, Lee MH. Overview of therapeutic drug monitoring. Korean J Intern Med. 2009;24(1):1–10. doi: 10.3904/kjim.2009.24.1.1.
Simeoli R, Dorlo TPC, Hanff LM, Huitema ADR, Dreesen E. Editorial:Therapeutic Drug Monitoring (TDM): AUseful Tool for Pediatric Pharmacology Applied to Routine Clinical Practice. Front Pharmacol. 2022;13. doi: 10.3389/fphar.2022.931843.
Jung O, Gechter JL, Wunder C, Paulke A, Bartel C, Geiger H, Toennes SW. Resistant hypertension? Assessment of adherence by toxicological urine analysis. J Hypertens. 2013;31(4):766–74. doi: 10.1097/HJH.0b013e32835e2286.
Gross AS. Best practice in therapeutic drug monitoring. Br J Clin Pharmacol. 2001;52. doi: 10.1046/j.1365-2125.2001.0520s1005.x.
DiPiro JT, Spruill WJ, Blouin RA, Wade WE, Pruemer JM. Introduction to pharmacokinetics and pharmacodynamics. In: DiPiro JT, Spruill WJ, Blouin RA, Wade WE, Pruemer JM, editors. Concepts in Clinical Pharmacokinetics. Bethesda: ASHP; 2002; pp. 1–11.
Basu S, Garg S, Sharma N, Singh MM. Improving the assessment of medication adherence: challenges and considerations with a focus on low-resource settings. Tzu Chi Med J. 2019;31(2):73–80. doi: 10.4103/tcmj.tcmj_177_18.
Vermeire E, Hearnshaw H, Van Royen P, Denekens J. Patient adherence to treatment: three decades of research. A comprehensive review. J Clin Pharm Ther. 2001;26(5):331–42. doi: 10.1046/j.1365-2710.2001.00363.x.
Forbes CA, Deshpande S, Sorio-Vilela F, Kutikova L, Duffy S, Gouni-Berthold I, et al. A systematic literature review comparing methods for the measurement of patient persistence and adherence. Curr Med Res Opin. 2018;34:1613–25. doi: 10.1080/03007995.2018.1477747.
de Achaval S, Suarez-Almazor ME. Treatment adherence to disease-modifying antirheumatic drugs in patients with rheumatoid arthritis and systemic lupus erythematosus. Int J Clin Rheumatol. 2010;5:313–26. doi: 10.2217/ijr.10.15.
Garfield S, Clifford S, Eliasson L, Barber N, Willson A. Suitability of measures of self-reported medication adherence for routine clinical use: a systematic review. BMC Med Res Methodol. 2011;11. doi: 10.1186/1471-2288-11-149.
Stirratt MJ, Dunbar-Jacob J, Crane HM, Simoni JM, Czajkowski S, Hilliard ME, et al. Self-report measures of medication adherence behavior: recommendations on optimal use. Transl Behav Med. 2015;5(4):470–82. doi: 10.1007/s13142-015-0315-2.
Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care. 1986;24(1):67–74. doi: 10.1097/00005650-198601000-00007.
Park SP, Lee EYJ. How should medical researchers respond to false copyright infringement claims? Sci Ed. 2019;6(2):137–41.
Morisky DE, Ang A, Krousel-Wood M, Ward HJ. Predictive validity of a medication adherence measure in an outpatient setting. J Clin Hypertens. 2008;10(5):348–54. doi: 10.1111/j.1751-7176.2008.07572.x.
Tesfaye W, Peterson G. Self-reported medication adherence measurement tools: Some options to avoid a legal minefield. J Clin Pharm Ther. 2022;47(3):363–8. doi: 10.1111/jcpt.13515.
Nguyen TM, La Caze A, Cottrell N. What are validated self-report adherence scales really measuring?: a systematic review. Br J Clin Pharmacol. 2014;77(3):427–45.
Bhattacharya D, Brown TJ, Clark AB, Dima AL, Easthall C, Taylor N, Li Z. Validation of the Identification of Medication Adherence Barriers Questionnaire (IMAB-Q); a Behavioural Science-Underpinned Tool for Identifying Non-Adherence and Diagnosing an Individual's Barriers to Adherence. Patient Prefer Adherence. 2023;17:2991–3000. doi: 10.2147/PPA.S427207.
Müller S, Kohlmann T, Wilke T. Validation of the Adherence Barriers Questionnaire – an instrument for identifying potential risk factors associated with medication-related non-adherence. BMC Health Serv Res. 2015;15. doi: 10.1186/s12913-015-0809-0.
Gagnier JJ, Lai J, Mokkink LB, Terwee CB. COSMIN reporting guideline for studies on measurement properties of patient-reported outcome measures. Qual Life Res. 2021;30(8):2197–218. doi: 10.1007/s11136-021-02822-4.
Kwan YH, Weng SD, Loh DHF, Phang JK, Oo LJY, Blalock DV, et al. Measurement properties of existing patient-reported outcome measures on medication adherence: Systematic review. J Med Internet Res. 2020;22(10). doi: 10.2196/19179.
Checchi KD, Huybrechts KF, Avorn J, Kesselheim AS. Electronic medication packaging devices and medication adherence: a systematic review. JAMA. 2014;312(12):1237–47. doi: 10.1001/jama.2014.10059.
Aldeer M, Javanmard M, Martin RP. A Review of Medication Adherence Monitoring Technologies. Appl Syst Innov. 2018;1(2). doi: 10.3390/asi1020014.
Al Shammari YH, Al Shammari HA, Barak TMB, Alharbi BS, Alshammari ST, Alnais SA, et al. Smart pills: the future of adherence monitoring. Int J Health Sci. 2019;3:1–15. doi: 10.53730/ijhs.v3nS1.14916.
Kiourti A, Nikita KS. A review of in-body biotelemetry devices: Implantables, ingestibles, and injectables. IEEE Trans Biomed Eng. 2017;64:1422–30. doi: 10.1109/TBME.2017.2668612.
Park LG, Howie-Esquivel J, Dracup K. Electronic measurement of medication adherence. West J Nurs Res. 2015;37(1):28–49. doi: 10.1177/0193945914524492.
Chai PR, Rosen RK, Boyer EW. Ingestible biosensors for real-time medicaladherence monitoring: MyTMed. Proc Annu Hawaii Int Conf Syst Sci. 2016;2016:3416–23. doi: 10.1109/HICSS.2016.426.
Eisenberger U, Wüthrich RP, Bock A, Ambühl P, Steiger J, Intondi A, et al. Medication adherence assessment: high accuracy of the new Ingestible Sensor System in kidney transplants. Transplantation. 2013;96(3):245–50. doi: 10.1097/TP.0b013e31829b7571.
Trappe W, Howard R, Moore RS. Low-energy security: Limits and opportunities in the Internet of things. IEEE Secur Priv. 2015;13:14–21. doi: 10.1109/MSP.2015.7.
Silva DS, Snyder J. The ethics of new technologies to track drug adherence. CMAJ. 2018;190(40):1209–10.
Diaz E, Levine HB, Sullivan MC, Sernyak MJ, Hawkins KA, Cramer JA, Woods SW. Use of the medication event monitoring system to estimate medication compliance in patients with schizophrenia. J Psychiatry Neurosci. 2001;26(4):325–9.
Schnorrerova P, Matalová P, Wawruch M. Medication adherence: Measurement methods and approaches. Bratisl Lek Listy. 2024;125(4). doi: 10.4149/BLL_2024_40.
Dalli LL, Kilkenny MF, Arnet I, Sanfilippo FM, Cummings DM, Kapral MK, et al. Towards better report-ing of the proportion of days covered method in cardiovas-cular medication adherence: A scoping review and new tool TEN-SPIDERS. Br J Clin Pharmacol. 2022;88(10):4427–42. doi: 10.1111/bcp.15391.
Stirratt MJ, Curtis JR, Danila MI, Hansen R, Miller MJ, Gakumo CA. Advancing the science and practice of medication adherence. J Gen Intern Med. 2018;33(2):216–22. doi: 10.1007/s11606-017-4198-4.
Claxton AJ, Cramer J, Pierce C. A systematic review of the associations between dose regimens and medication compliance. Clin Ther. 2001;23(8):1296–310. doi: 10.1016/s0149-2918(01)80109-0.
George J, Elliott RA, Stewart DC. A systematic review of interventions to improve medication taking in elderly patients prescribed multiple medications. Drugs Aging. 2008;25(4):307–24. doi:10.2165/00002512-200825040-00004.
Ingersoll KS, Cohen J. The impact of medication regimen factors on adherence to chronic treatment: a review of literature. J Behav Med. 2008;31(3):213–24. doi: 10.1007/s10865-007-9147-y.
Boeni F, Hersberger KE, Arnet I. Multidrug punch cards in primary care: A mixed methods study on patients’ preferences and impact on adherence. Front Pharmacol. 2014;5. doi: 10.3389/fphar.2014.00229.
Dietrich FM, Hersberger KE, Arnet I. Benefits of medication charts provided at transitions of care: A narrative systematic review. BMJ Open. 2020;10(10). doi: 10.1136/bmjopen-2020-038037.
Viswanathan M, Golin CE, Jones CD, Ashok M, Blalock SJ, Wines RC, et al. Interventions to improve adherence to self-administered medications for chronic diseases in the United States: a systematic review. Ann Intern Med. 2012;157(11):785–95. doi: 10.7326/0003-4819-157-11-201212040-00538.
Gibson PG, Powell H, Wilson A, Abramson M, Haywood P, Bauman A, et al. Self-management education and regular practitioner review for adults with asthma (review). Cochrane Database Syst Rev. 2003. doi:10.1002/14651858.CD001117.
Kotses H, Bernstein IL, Bernstein DI, Reynolds RV, Korbee L, Wigal JK, et al. A self-management program for adult asthma. Part I: development and evaluation. J Allergy Clin Immunol. 1995;95(2):529–40. doi: 10.1016/S0091-6749(95)70081-6.
Taitel MS, Kotses H, Bernstein IL, Bernstein DI, Creer TL. A self-management program for adult asthma. Part II: cost-benefit analysis. J Allergy Clin Immunol. 1995;95(3):672–6. doi: 10.1016/S0091-6749(95)70297-0.
Conn VS, Ruppar TM, Enriquez M, Cooper PS, Chan KC. Healthcare provider targeted interventions to improve medication adherence: systematic review and meta-analysis. Int J Clin Pract. 2015;69(8):889–99. doi: 10.1111/ijcp.12632.
Evans HM. Do patients have duties? J Med Ethics. 2007;33(12):689–94. doi: 10.1136/jme.2007.021188.
Baumgartner PC, Comment N, Hersberger KE, Arnet I. Development and testing of a framework for defining a strategy to address medication adherence during patient encounters in community pharmacies. Explor Res Clin Soc Pharm. 2022;5:100123. doi: 10.1016/j.rcsop.2022.100123.
Rajiah K, Sivarasa S, Maharajan MK. Impact of Pharmacists' Interventions and Patients' Decision on Health Outcomes in Terms of Medication Adherence and Quality Use of Medicines among Patients Attending Community Pharmacies: A Systematic Review. Int J Environ Res Public Health. 2021;18(9):4392. doi: 10.3390/ijerph18094392.
- Autori zadržavaju autorska prava i pružaju časopisu pravo prvog objavljivanja rada i licenciraju ga "Creative Commons Attribution licencom" koja omogućava drugima da dele rad, uz uslov navođenja autorstva i izvornog objavljivanja u ovom časopisu.
- Autori mogu izraditi zasebne, ugovorne aranžmane za neekskluzivnu distribuciju članka objavljenog u časopisu (npr. postavljanje u institucionalni repozitorijum ili objavljivanje u knjizi), uz navođenje da je članak izvorno objavljen u ovom časopisu.
- Autorima je dozvoljeno i podstiču se da postave objavljeni članak onlajn (npr. u institucionalni repozitorijum ili na svoju internet stranicu) pre ili tokom postupka prijave rukopisa, s obzirom da takav postupak može voditi produktivnoj razmeni ideja i ranijoj i većoj citiranosti objavljenog članka (Vidi Efekti otvorenog pristupa).